PURPOSE OF REVIEW: To summarize recent findings regarding the public health impact of androgen abuse. RECENT FINDINGS: Abuse of androgens (also called 'anabolic-androgenic steroids') has grown into a major worldwide substance abuse problem involving tens of millions of individuals, of whom about 98% are men. Most androgen abusers are still under age 50 today, and thus, the long-term effects of these drugs are only beginning to be understood. Recent studies confirm that long-term supraphysiologic androgen exposure produces cardiovascular toxicity, characterized especially by cardiomyopathy and atherosclerotic disease. Withdrawal from androgens after long-term use may produce prolonged and sometimes irreversible hypogonadism in men. Supraphysiologic androgen levels may sometimes cause irritability, aggressiveness, and violence, whereas androgen withdrawal may cause depression. However, these psychiatric effects are idiosyncratic, affecting only a minority of users. Emerging evidence now also suggests that long-term androgen exposure may cause neurotoxicity, raising the possibility that aging androgen abusers may be at increased risk for dementia. Several recent studies have also described androgen-induced hepatotoxicity, nephrotoxicity, and adverse musculoskeletal effects. SUMMARY: Recent studies have demonstrated marked adverse effects of long-term androgen abuse. As increasing numbers of androgen abusers reach middle age, these effects will likely represent an emerging public health problem.
PURPOSE OF REVIEW: To summarize recent findings regarding the public health impact of androgen abuse. RECENT FINDINGS: Abuse of androgens (also called 'anabolic-androgenic steroids') has grown into a major worldwide substance abuse problem involving tens of millions of individuals, of whom about 98% are men. Most androgen abusers are still under age 50 today, and thus, the long-term effects of these drugs are only beginning to be understood. Recent studies confirm that long-term supraphysiologic androgen exposure produces cardiovascular toxicity, characterized especially by cardiomyopathy and atherosclerotic disease. Withdrawal from androgens after long-term use may produce prolonged and sometimes irreversible hypogonadism in men. Supraphysiologic androgen levels may sometimes cause irritability, aggressiveness, and violence, whereas androgen withdrawal may cause depression. However, these psychiatric effects are idiosyncratic, affecting only a minority of users. Emerging evidence now also suggests that long-term androgen exposure may cause neurotoxicity, raising the possibility that aging androgen abusers may be at increased risk for dementia. Several recent studies have also described androgen-induced hepatotoxicity, nephrotoxicity, and adverse musculoskeletal effects. SUMMARY: Recent studies have demonstrated marked adverse effects of long-term androgen abuse. As increasing numbers of androgen abusers reach middle age, these effects will likely represent an emerging public health problem.
Authors: Johanna Seitz; Amanda E Lyall; Gen Kanayama; Nikos Makris; James I Hudson; Marek Kubicki; Harrison G Pope; Marc J Kaufman Journal: Psychiatry Res Neuroimaging Date: 2016-12-10 Impact factor: 2.376
Authors: Gen Kanayama; Matthew Boynes; James I Hudson; Alison E Field; Harrison G Pope Journal: Drug Alcohol Depend Date: 2006-11-28 Impact factor: 4.492
Authors: Dhananjay R Namjoshi; Wai Hang Cheng; Michael Carr; Kris M Martens; Shahab Zareyan; Anna Wilkinson; Kurt A McInnes; Peter A Cripton; Cheryl L Wellington Journal: PLoS One Date: 2016-01-19 Impact factor: 3.240
Authors: Jon Jarløv Rasmussen; Christian Selmer; Peter Busch Østergren; Karen Boje Pedersen; Morten Schou; Finn Gustafsson; Jens Faber; Anders Juul; Caroline Kistorp Journal: PLoS One Date: 2016-08-17 Impact factor: 3.240
Authors: Lars T Westlye; Tobias Kaufmann; Dag Alnæs; Ingunn R Hullstein; Astrid Bjørnebekk Journal: Neuroimage Clin Date: 2016-11-17 Impact factor: 4.881
Authors: Giuseppe Davide Albano; Francesco Amico; Giuseppe Cocimano; Aldo Liberto; Francesca Maglietta; Massimiliano Esposito; Giuseppe Li Rosi; Nunzio Di Nunno; Monica Salerno; Angelo Montana Journal: Healthcare (Basel) Date: 2021-01-19
Authors: Artur Lemiński; Markiian Kubis; Krystian Kaczmarek; Adam Gołąb; Arkadiusz Kazimierczak; Katarzyna Kotfis; Marcin Słojewski Journal: Int J Environ Res Public Health Date: 2022-02-14 Impact factor: 3.390
Authors: Mohamed Raafat; Amr A Kamel; Alaa H Shehata; Al-Shaimaa F Ahmed; Asmaa M A Bayoumi; Rabab A Moussa; Mohammed A S Abourehab; Mahmoud El-Daly Journal: Pharmaceuticals (Basel) Date: 2022-01-22